Biogen Idec shareholders may have dealt Carl Icahn a knockout blow this morning when they voted against seating his candidates on the board of directors. That may be the end of Icahn’s often colorful attempts to force a sale of the company. So what’s next for a standalone Biogen?
Perhaps the most important question facing the [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment